Search Results

A person holding a measuring tape around her waist.
MBT Desk
3 min read
Experimental triple-hormone therapy achieved up to 24.2% weight loss in Phase 2 trials, but it remains under investigation and is not yet FDA approved.
A diverse group of people sharing a meal at a table.
MBT Desk
4 min read
How weight-loss drugs like GLP-1 agonists may influence the brain’s reward system and addictive behaviours.
A young woman in a casual outfit stands in a bright room, focused on her smartphone.
MBT Desk
4 min read
GLP-1 drugs may help treat more than obesity, but research is still evolving.
A person holds a syringe pen against a striped background.
MBT Desk
5 min read
GLP-1 drugs may help people with brain metastases and diabetes live longer.
Box of Ozempic / Wegovy Weight Loss Drug, (Semaglutiude) 0.5mg in a pharmacy
FDA inspection finds safety reporting gaps at Novo Nordisk involving serious adverse events linked to widely used GLP-1 diabetes and obesity drugs
Michelle laying unconscious while doctors treat her in the mobile ambulance.
Arushi Roy Chowdhury
2 min read
Fake Ozempic Weight-Loss Injections Sold on Social Media Trigger Life-Threatening Medical Emergency in Oxfordshire Woman.
Read More
logo
Medbound Times
www.medboundtimes.com